A comprehensive view of Respiratory / Lung Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Janssen Pharmaceutical Companies Secures FDA Approval for NSCLC Therapy and Champions Cardiac Health Equity

Pfizer reports its bivalent vaccine ABRYSVO maintains high protective efficacy for both RSV A and RSV B disease in adults aged 60 or older through two seasons after one dose; RSV infections account for approximately 60,000-160,000 hospitalizations in US

AstraZeneca Seeks Patent for Methods for Treating Small Cell Lung Cancer and Other Neuroendocrine Cancers

Moderna concludes construction of respiratory mRNA vaccine manufacturing facility in Laval, Quebec, with operations set to begin by 2025; the initiative is part of a partnership with the Canadian government and is partly funded by Quebec

Dupixent shows promising results in reducing airway inflammation and mucus build-up in adults with severe asthma, according to Sanofi; the findings were presented at the 2024 American Academy of Allergy, Asthma, and Immunology Annual Meeting

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count